1The Genetics and Prenatal Diagnosis Center, the Department of Obstetrics and Gynecology, the First Af?liated Hospital of Zhengzhou University, Zhengzhou 450000, China
2The Department of Molecular Pathology, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou 450000, China
3The Department of Ophthalmology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, China
Objective:To detect and analyze the genetic etiology of retinoblastoma patients, and to provide a theoretical basis for gene diagnosis, genetic counseling and prenatal diagnosis of patients and theirfamilies.Methods:This was an experimental study. Clinical material from 12 families were collected and genomic DNA was extracted from the peripheral blood of patients and related subjects. An FFPE sample was collected from adeceased patient and genomic DNA was extracted. Genomic DNA was extracted from the amniotic ?uid cells of the pregnant women. The mutation was screened by using targeted sequencing,and PCR-Sanger sequencing was used to verify the selected mutations. PubMed and related databases were searched. Pathogenic analysis of the mutation and the mutation effect was interpreted by protein prediction software. The pathogenicity of candidate mutations was determined and graded according to a joint consensus recommended by the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. According to the pathogenic mutation of the proband in the family, the relatedpregnant women underwentRB1gene prenatal diagnosis.Results:Different pathogenic gene variations,6 of which were known pathogenic variations, were detected in 8 of the 12 selected families, and the positive rate was 67%. And theRB1gene c.2404dupG (p.N803Efs*12) and c.1380_1381insCTTA (p.K462Tfs*2)detected in this study were novel genes. All of them were pathogenic based on comprehensive analysisof the eight differentRB1gene mutations detected in this study.Conclusions:Eight of the twelve families with retinoblastoma were diagnosed withRB1mutation. The study found two new mutations in retinoblastoma. Based on the results of the genetic diagnosis, the related families received effective genetic counseling and prenatal diagnosis.
白周现,张翠云,邵敬芝,等. 12家系视网膜母细胞瘤基因诊断的回顾性分析[J]. 中华眼视光学与视觉科学杂志, 2021, 23(11): 820-826.
Zhouxian Bai, Cuiyun Zhang, Jingzhi Shao, et al. Retrospective Study on Gene Diagnosis of Retinoblastoma in 12 Families. Chinese Journal of Optometry Ophthalmology and Visual science, 2021, 23(11): 820-826. DOI: 10.3760/cma.j.cn115909-20210520-00201
Sampieri K, Hadjistilianou T, Mari F, et al. Mutational screening of the RB1 gene in Italian patients with retinoblastoma reveals11 novel mutations. J Hum Genet, 2006, 51(3): 209-216. DOI: 10.1007/s10038-005-0348-3.
[2]
Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell, 2011, 144(5): 646-674. DOI: 10.1016/ j.cell.2011.02.013.
[3]
Tucker T, Friedman JM. Pathogenesis of hereditary tumors: beyond the “two-hit” hypothesis. Clin Genet, 2002, 62(5): 345- 357. DOI: 10.1034/j.1399-0004.2002.620501.x.
[4]
Fitzgerald PH, Stewart J, Suckling RD. Retinoblastoma mutation rate in New Zealand and support for the two-hit model. Hum Genet, 1983, 64(2): 128-130. DOI: 10.1007/BF00327107.
[5]
Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med, 2015, 17(5): 405-424. DOI: 10.1038/gim.2015.30.
Yandell DW, Campbell TA, Dayton SH, et al. Oncogenic point mutations in the human retinoblastoma gene: their application to genetic counseling. N Engl J Med, 1989, 321(25): 1689-1695. DOI: 10.1056/NEJM198912213212501.
[8]
Cowell JK, Smith T, Bia B. Frequent constitutional C to T mutations in CGA-arginine codons in the RB1 gene produce premature stop codons in patients with bilateral (hereditary) retinoblastoma. Eur J Hum Genet, 1994, 2(4): 281-290. DOI: 10.1159/000472372.
[9]
de Oliveira Reis AH, de Carvalho IN, de Sousa Damasceno PB, et al. Influence of MDM2 and MDM4 on development and survival in hereditary retinoblastoma. Pediatr Blood Cancer, 2012, 59(1): 39-43. DOI: 10.1002/pbc.24014.
[10]
Parsam VL, Kannabiran C, Honavar S, et al. A comprehensive, sensitive and economical approach for the detection of mutations in the RB1 gene in retinoblastoma. J Genet, 2009, 88(4): 517- 527. DOI: 10.1007/s12041-009-0069-z.
[11]
Abouzeid H, Munier FL, Thonney F, et al. Ten novel RB1 genemutations in patients with retinoblastoma. Mol Vis, 2007, 13(94- 96): 1740-1745. DOI: 10.1016/j.visres.2007.08.004.
Dyson NJ. RB1: a prototype tumor suppressor and an enigma. Genes Dev, 2016, 30(13): 1492-1502. DOI: 10.1101/ gad.282145.116.
[14]
Shiio Y, Yamamoto T, Yamaguchi N. Negative regulation of Rb expression by the p53 gene product. Proc Natl Acad Sci USA, 1992, 89(12): 5206-5210. DOI: 10.1073/pnas.89.12.5206.
[15]
Hsieh JK, Chan FS, O'Connor DJ, et al. RB regulates the stability and the apoptotic function of p53 via MDM2. Mol Cell, 1999, 3(2): 181-193. DOI: 10.1016/s1097-2765(00)80309-3.
[16]
García-Cao M, Gonzalo S, Dean D, et al. A role for the Rb family of proteins in controlling telomere length. Nat Genet, 2002, 32(3): 415-419. DOI: 10.1038/ng1011.
[17]
Laurie NA, Donovan SL, Shih CS, et al. Inactivation of the p53 pathway in retinoblastoma. Nature, 2006, 444(7115): 61-66. DOI: 10.1038/nature05194.
[18]
Xu XL, Singh HP, Wang L, et al. Rb suppresses human coneprecursor-derived retinoblastoma tumours. Nature, 2014, 514(7522): 385-388. DOI: 10.1038/nature13813.
Lohmann DR, Gallie BL. Retinoblastoma: revisiting the model prototype of inherited cancer. Am J Med Genet C Semin Med Genet, 2004, 129C(1): 23-28. DOI: 10.1002/ajmg.c.30024.
浙公网安备 33030202001892号